Journal Articles

Pilot study: haemoglobin spray in the treatment of chronic diabetic foot ulcers

Share this article

Pilot study: haemoglobin spray in the treatment of chronic diabetic foot ulcers

Paul Chadwick
7 November 2014

Wounds cannot heal without oxygen. In fact, healing wounds demand more oxygen than healthy tissue — yet chronic wounds are often at least partly due to vascular insufficiency. A novel spray aims to make use of haemogolobin, the transport molecule for oxygen in the bloodstream, to bind atmospheric oxygen and deliver it to the hypoxic wound bed. The product, Granulox® (Infirst Healthcare), may be of particular interest in patients with impaired levels of tissue perfusion/oxygenation, which may be impeding wound healing.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.